Search

everythinglearnresearchcommunity

for

Search:↓

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Dermatologists need to understand hair products to treat hair and scalp issues better.

Women look young for their age due to larger lips, less sun damage, and genes that prevent gray hair and wrinkles.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Higher doses of cranial irradiation are linked to permanent hair loss.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Different hair evaluation methods have their own pros and cons, and using multiple methods together is best for accurate hair loss diagnosis and tracking.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Minoxidil and finasteride effectively treat hair loss.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Dermatoscopy is a useful tool for diagnosing hair disorders and can help choose samples for more detailed analysis.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Caucasian women's hair appears thickest in their 20s, with perceived thinning after mid-30s due to both decreasing density and diameter.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

KFSD is a rare condition causing scarring hair loss, with no effective treatment known at the time of the report.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.